SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1
- Hemasphere. 2019 Oct 1;3(6):e301. doi: 10.1097/HS9.0000000000000301.
Affiliations
- 1. Department of Pediatric Hematology, Oncology and Immunology - University of Heidelberg, Germany.
- 2. Molecular Medicine Partnership Unit, Heidelberg, Germany.
- 3. Silence Therapeutics GmbH, Berlin, Germany.
PMID: 31976476
DOI: 10.1097/HS9.0000000000000301
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cardiovascular Disease
-
Research Areas: Others